On Wednesday, Shares of Visa Inc (NYSE:V), gained 0.93% to $69.60.
On Wednesday, September 16, Jim McCarthy, Executive Vice President, Innovation & Planned Partnerships, will present at the Deutsche Bank 2015 Technology Conference in Las Vegas, Nevada. The negotiation will start at 1:20 p.m. Pacific Time and last for about 35 minutes. A listen-only audio webcast and replay will be accessible for 30 days on the Investor Relations web site at http://investor.visa.com.
On Tuesday, September 29, Brad Greene, Vice President, Digital Developed Markets, will present at the Jefferies 2015 West Coast Electronic Payments Summit in Half Moon Bay, California. The negotiation will start at 10:30 a.m. Pacific Time and last for about 45 minutes.
Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Shares of Synergetics USA Inc (NASDAQ:SURG), inclined 49.89% to $6.58, during its last trading session.
Synergetics USA, and Valeant Pharmaceuticals International, a wholly-owned partner of Valeant Pharmaceuticals International, Inc. (NYSE:VRX), declared that they have reached a definitive agreement under which Valeant will acquire Synergetics for $6.50 per share in cash. In addition to the upfront cash payment, Synergetics stockholders will receive additional cash payments of up to $1.00 per share if specified sales milestones are achieved following the closing. The transaction is predictable to close in the fourth quarter of 2015 and is subject to customary closing conditions and regulatory approvals.
The $6.50 per share cash consideration represents a 48.1% premium to Synergetics’ closing share price on September 1, 2015, the last trading day preceding to declaration, and a 39.6% premium to the three-month average trading price.
“We are happy to reach a contract with Valeant, which is a logical partner to maximize our Company’s growth opportunities and, importantly, this agreement creates immediate and compelling value for our shareholders,” said David M. Hable, the Company’s President, and Chief Executive Officer. “The combined strengths of both companies will expand the breadth of our offerings and create a more effective competitor that is better able to meet our customers’ needs in the ophthalmology and neurosurgery markets.”
Synergetics USA, Inc., a medical device company, provides precision surgical devices, surgical equipment, and consumables primarily for the ophthalmology and neurosurgery markets in the United States and internationally.
Finally, PVH Corp (NYSE:PVH), ended its last trade with 1.24% gain, and closed at $118.26.
PVH Corp., stated 2015 second quarter results.
Overview of Second Quarter Results:
Earnings per share on a non-GAAP basis was $1.37, inclusive of a $0.31 negative impact primarily related to foreign currency exchange rates contrast to the preceding year. Earnings per share on a non-GAAP basis not taking into account the negative impact primarily related to foreign currency exchange rates was $1.68, or an improvement of 11% contrast to the preceding year’s second quarter earnings per share on a non-GAAP basis of $1.51.
GAAP earnings per share were $1.22 contrast to $1.52 for the preceding year’s second quarter.
Revenue raised 2% on a constant currency basis (reduced 6% on a GAAP basis) contrast to the preceding year’s second quarter revenue of $1.98 billion. As contrast to the preceding year’s second quarter, revenues raised 5% in the Tommy Hilfiger business on a constant currency basis (reduced 7% on a GAAP basis); raised 3% in the Calvin Klein business on a constant currency basis (reduced 4% on a GAAP basis); and reduced 6% in the Heritage Brands business.
PVH Corp. operates as an apparel company in the United States and internationally. It designs, markets, and retails men’s and women’s apparel and accessories, branded dress shirts, neckwear, sportswear, jeanswear, intimate apparel, swim products, handbags, footwear, golf apparel, fragrances, cosmetics, eyewear, hosiery, socks, jewelry, watches, outerwear, small leather goods, and home furnishings, in addition to other related products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
